Analysis on nosocomial infection of drug-resistant bacteria under the DRGs and economic burden
Objective To analyze nosocomial infection of multidrug-resistant organism(MDRO)under the DRGs and economic burden,so as to provide basis for prevention and control of MDRO.Methods Retrospectively analyzee MDRO infection in our hospital in 2021,the patients in the DRGs group were divided into MDRO hospital infection group and non-NDRO infection group,and the hospital stay and hospitalization cost of the two groups were analyzed.Results In 2021,there were a total of 73,150 hospitalized patients of DRGs and a total of 188 cases MDRO nosocomial infection occurred,with an infection rate of 0.26％.The number of hospital infection DRGs in MDRO accounted for 11.64％of the total number of DRGs in the hospital,and lower respiratory tract infection ranked first.Tthe hospitalization time of the MDRO group with hospital infection was 14.5days longer than that of non-MDRO group,and the total hospitalization cost increased by 47188.03 RMB.The cost of medical treatment,medical technology,nursing care,drugs,consumables,antibacterial drugs,blood transfusion and other costs in the MDRO group were higher than those in the non-MDRO group(P＜0.001).Conclusions According to the patient treatment data under the DRGs payment,we can know the patients who are susceptible to MDRO infection and the departments where the infected patients are located,as well as the greatly increased medical costs.Relevant departments should pay attention to the payment of DRGs at the right time and take timely targeted measures,which can reduce the infection rate and economic burden of patients with MDRO.
diagnosis related groupsnosocomial infectionmultidrug-resistant organismeconomic burden
NETL
NSTL
万方数据
